Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

ClinicalTrials.gov ID: NCT03712345

Public ClinicalTrials.gov record NCT03712345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase II Efficacy and Safety Study of IFX-1 in Add-On to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the safety and tolerability of two dose regimens of IFX-1 as add-on to standard of care (SOC) in subjects with GPA and MPA compared with placebo.

Study identification

NCT ID
NCT03712345
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
InflaRx GmbH
Industry
Enrollment
20 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2018 (Actual)
Primary completion
Sep 10, 2020 (Actual)
Completion
May 3, 2021 (Actual)
Last update posted
May 26, 2022

2018 – 2021

United States locations

U.S. sites
33
U.S. states
23
U.S. cities
33
Facility City State ZIP Site status
Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
Loma Linda University Clinical Trial Center Loma Linda California 92354 —
Science Connections, LLC Doral Florida 33166 —
University of Miami Miami Florida 33136 —
Rush University Medical Center Chicago Illinois 60612 —
University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas 66160 —
LSU Health Sciences Center Shreveport Shreveport Louisiana 71103 —
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University Of MI Medcl Ctr-RHU Ann Arbor Michigan 48109 —
Henry Ford Hospital Detroit Michigan 48084 —
University of Minnesota Minneapolis Minnesota 55414 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University St Louis Missouri 63110 —
University of New Mexico Albuquerque New Mexico 87131 —
Northwell Health, LLC PRIME New Hyde Park New York 11042 —
Hospital for Special Surgery New York New York 10021 —
University of Rochester Medical Center - Strong Memorial Hospital Rochester New York 14642 —
UNC Kidney Center, UNC-CH Division of Nephrology and Hypertension Chapel Hill North Carolina 27599-7155 —
Trinity Medical Group Minot North Dakota 58701 —
Ohio State University Clinical Trials Management Office Columbus Ohio 43203 —
Oregon Health & Science University Portland Oregon 97239 —
BRCR Medical Center, Inc. Camp Hill Pennsylvania 17011 —
Altoona Center for Clinical Research, P.C. Duncansville Pennsylvania 16635 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Rhode Island Hospital Providence Rhode Island 02903 —
Low Country Rheumatology, PA North Charleston South Carolina 29406 —
Adriana Pop Moody Clinic PA Corpus Christi Texas 78404 —
Texas Health Resources Dallas Texas 75287 —
Texas Research Institute Fort Worth Texas 76104 —
Pioneer Research Solutions, Inc. Houston Texas 77099 —
UVA University Physicians Charlottesville Charlottesville Virginia 22903 —
West Virginia University Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03712345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03712345 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →